Cognition and MRI in MS Jeffrey Wilken, Ph.D. Director of Neuropsychology Department of Veterans Affairs Washington, DC Assistant Clinical Professor University.

Slides:



Advertisements
Similar presentations
Defining suboptimal response to MS treatment: MRI outcome
Advertisements

Corpus Callosum Damage Predicts Disability Progression and Cognitive Dysfunction in Primary-Progressive MS After Five Years.
Study Design 121 Relapsing-remitting MS patients randomized to –Stress Management Therapy MS active treatment* 16 individual sessions conducted over 24.
Emmanuel A Stamatakis Centre for Speech, Language and the Brain, Department of Experimental Psychology, University of Cambridge School of Psychological.
Speed of processing, the missing measure in early detection of MCI? Ruth O’Hara March 13 th 2001 Yogesh Shah.
Frontotemporal Dementia
Young Onset Neurodegeneration study. Neurology at the Memory Clinic Dr Thomas Monaghan SpR in Neurology Memory, Cognitive Studies and Behavioral Neurology.
Presymptomatic HD Disease onset currently defined by clinical detection of motor abnormalities Questions: 1) Are more subtle but clinically important signs.
J. Stephen Huff, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.
Public Health Julie C. Chapman, PsyD Director of Neuroscience War Related Illness & Injury Study Center Veterans Affairs Medical Center, Washington, DC.
Original Article B-Cell Depletion with Rituximab in Relapsing- Remitting Multiple Sclerosis Stephen L. Hauser, M.D., Emmanuelle Waubant, M.D., Ph.D., Douglas.
Screening By building screening for symptoms of VCI into regular workflows or practice, health care providers are participating in Taking Action to address.
Mild Cognitive Impairment as a Target for Drug Development Steven H. Ferris, Ph.D. Silberstein Aging and Dementia Research Center New York University School.
Alexander I. Tröster, Ph.D. Department of Neurology
GAL-INT-6 The safety and efficacy of galantamine in patients with Vascular dementia or AD with cerebrovascular disease Sean Lilienfeld MD, FCP, MMed Janssen.
How Alzheimer’s Disease Differs from Frontal Temporal Lobe Dementia (Pick’s Disease) Josepha A. Cheong, MD University of Florida Departments of Psychiatry.
Dr. Omranifard MD 12 may 2015 Depression is one of the most prevalent psychiatric disorders in late life with devastating health consequences. It could.
Ralph HB Benedict, PhD The Jacobs Neurological Institute
A ACHOUR, S JERBI OMEZZINE, S YOUNES 1, S BOUABID, MH SFAR 1, HA HAMZA. Department of Medical Imaging, Tahar Sfar University Hospital Center, Mahdia, Tunisia.
JLC Multiple Sclerosis and the Mind: Memory Loss and Cognitive Impairment Jonathan L. Carter MD Director Mayo Clinic Scottsdale MS Center Jonathan.
JLC Cognitive Impairment Associated with Multiple Sclerosis Jonathan L. Carter, MD Director Mayo Clinic Scottsdale MS Center Jonathan L. Carter,
Natalizumab use for neuropsychological deficits in relapsing multiple sclerosis K. Edwards, 1,2 W. Goodman, 1 1 MS Center of Northeastern New York (Latham,
Chair Timothy L. Vollmer, MD Professor of Neurology
Idoia Corcuera-Solano, Gerard Reddy, Bradley Delman, Reade De Leacy, Dan Rettmann, Lawrence N Tanenbaum EP
© 2014 Direct One Communications, Inc. All rights reserved. 1 A New Era of Therapy in Multiple Sclerosis: Balancing the Options and Challenges Ahead Jennifer.
Introduction Multiple Sclerosis (MS) is a chronic inflammatory disease characterized by the demyelization of axons within the central nervous system (CNS).
Defining Mild Cognitive Impairment Steven T.DeKosky, M.D. Director, Alzheimer’s Disease Research Center University of Pittsburgh Pittsburgh, PA.
Delusions, behavioural symptoms, quality of life and caregiver effects in AD Delusions, behavioural symptoms, quality of life and caregiver effects in.
The Effect of Cognitive Fatigue on Language in Multiple Sclerosis Leena Maria Heikkola, Päivi Hämäläinen and Juhani Ruutiainen Åbo Akademi University,
ASNR 2015 Poster# EP-19 Effect of Chemotherapy on Brain Structure and Cognition in Older Women with Breast Cancer: a Brain MRI Study 1 Bihong T. Chen MD.
MRI as a Potential Surrogate Marker in the ADCS MCI Trial
Journal Insights Into: Oral Therapy for MS-Related Walking Impairment Supplemental Slides.
Neuroplasticity and Rehabilitation Strategies Robert K. Shin M.D. VA MS Center of Excellence Assistant Professor Departments of Neurology and Ophthalmology.
Do Instrumental Activities of Daily Living Predict Dementia at 1- and 2- Year Follow-Up? Findings from the Development of Screening Guidelines and Diagnostic.
Wei Chen CCNI Journal Club Alzheimer’s disease (AD): imaging & cognition imaging & cognition.
Understanding Mild Cognitive Impairment. Objectives Understand the concept of MCI Identify risk factors for progression to dementia Review clinical trial.
Peripheral and Central Nervous System Drugs Advisory Committee Meeting - March 14, Issues Related to the Development of Drugs for the Treatment.
Identifying and Tracking Changes in Cognition Related to NPH Sheldon Herring, Ph.D. Clinical Director Outpatient Brain Injury and Young Stroke Program.
White Matter Structural Integrity in Healthy Aging Adults and Patients With Alzheimer Disease: A Magnetic Resonance Imaging Study Bartzokis, et al. UCLA.
Wernicke’s encephalopaty: the best way to make early diagnosis D.MACHADO* – A.BOCCHIO *– A.M.ROSANO’*- M.OGGERO*- N.MILLOZ° – G.DOVERI°– T.MELONI* *Radiology.
Sven Haller Haller, Nguyen, Rodriguez, Emch, Gold, Bartsch, Lovblad, Giannakopoulos.
Cognitive Testing, Statistics and Dementia Ralph J. Kiernan Ph.D. 14 th May 2013.
Date of download: 6/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effect of Anti-CD25 Antibody Daclizumab in the Inhibition.
MR SPECTROCOPY AND MRI TO MEASURE TREATMENT OF NEURODEGENERATION MICHAEL W. WEINER Professor of Radiology, Medicine, Psychiatry, and Neurology, U.C.S.F.
Orienting network dysfunction in progressive multiple sclerosis (ID 208) Chalah MA 1,2, Palm U 1,3, Nguyen R 1,4, Créange A 1,4, Lefaucheur JP 1,2, Ayache.
In The Name of God. Multiple Sclerosis and Normal MRI new modalities for problems solving.
Multiple sclerosis – late onset. Authors: Vitalie Vacaras Vitalie Vacaras Damian Popescu Damian Popescu Radu Antonescu Radu Antonescu Anca Simu Anca Simu.
Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease  C Bjartmar, J.R Wujek, B.D Trapp  Journal of.
The Malfunctioning Mind: Degenerative Diseases of the Brain
Carrie M. Hersh, D.O., Robert Fox, M.D.
Differences in SPECT Perfusion in Children and Adolescents with ADHD
Metabolic Syndrome and Progression of Mild Cognitive Impairment
Four Known Types of MS Clinically isolated syndrome (CIS)
GRAY MATTER ATROPHY IN PEDIATRIC MS PATIENTS
Clinical Neuropsychology
Conclusion/Discussion
Evidence of Morphologic Differences in Children with Down Syndrome who Develop Infantile Spasms. Nicholas Phillips1,3 , Asim Choudhri2, James Wheless1,
Motor Perseveration Predicts Ideational Perseveration on the Wisconsin Card Sorting Test Matthew G Hall, M.S., Scott C Wollman, M.S., Lindsey A Frazier,
Tumefactive rebound of Multiple Sclerosis following cessation of Fingolimod   Sharfaraz Salam, Daniel Dunbar, Tim Lavin, Adrian Pace, Tatiana Mihalova.
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) and Review of Literature Zebin Xiao Department of.
What’s the Big Deal About Brain Atrophy and Neurodegeneration in RRMS?
Nat. Rev. Neurol. doi: /nrneurol
Figure 3 Associations of [11C](R)-PK11195 binding to disability and diffusion tensor imaging (DTI) changes in patients with MS Associations of [11C](R)-PK11195.
Neuroimaging Schizophrenia and Related Disorders
Figure 1 Clinical correlates of neurodegeneration in MS
Multiple sclerosis and cerebral endothelial dysfunction: Mechanisms
The MR scan of brain of our case vignette patient showing significant occipital lobe atrophy (especially left sided) with parietal lobe involvement as.
Figure 1 Anti-Epstein-Barr virus nuclear antigen-1 IgG quartile antibody status differences in MRI measures Anti-Epstein-Barr virus nuclear antigen-1 IgG.
Impact of approaches for clinical and radiological monitoring on predicting of short-term and long-term disability outcomes in multiple sclerosis Brian.
CNS VZV–IRIS (same patient as in Fig 3).
Presentation transcript:

Cognition and MRI in MS Jeffrey Wilken, Ph.D. Director of Neuropsychology Department of Veterans Affairs Washington, DC Assistant Clinical Professor University of Maryland at College Park

MS-Associated Inflammation Leads to... n Myelin Damage n Axonal Damage n Brain Atrophy

“Clinicians typically overestimate the relationship between cognitive dysfunction and physical disability.” Fischer JS, Foley FW, Aikens JE, et. al. What do we really know about cognitive dysfunction, affective disorders and stress in multiple sclerosis ? A practitioners guide. J Neurol Rehabil, 1994

Progression of Cognitive Dysfunction in MS Kujala et al. (1997): 3 year follow up n 23 cognitively normal MS pts. (EDSS 5.1) n 20 cognitively impaired MS pts. (EDSS 5.5) n Subjects non-impaired at baseline remained non- impaired. Subjects impaired at baseline deteriorated n Impaired patients progressed in memory/Visual Spatial/PASAT

Progression of Cognitive Dysfunction in MS n The evolution of cognitive dysfunction in early-onset MS was assessed over 10 years in 45 consecutive inpatients and outpatients n Of 37 patients who were not cognitively impaired on initial testing, only 20 remained so by the end of the 10-year follow up n Previously detected deficits in verbal memory, abstract reasoning, and linguistic processing confirmed. Problems in attention, spatial memory developed. n The proportion of patients who were cognitively impaired by the end of the 10-year follow-up reached 56% Amato et al. Arch Neurol. 2001;58:1602.

Correlations: Cognitive Impairment & Disability, Duration, and MRI    & EDSS & Duration & T 2 TLL MT

n Relationship between MR lesion burden and neuropsychological test scores n Location of lesions and neurobehavioral syndromes n Natural history studies: Correlations between changes in MR lesion burden and neuropsychological test scores MRI Correlates Of Neuropsychological Testing

Total T2 Lesion Area (sq cm) Number of Cognitive Tests Performed < 5 th Percentile of Controls * * Rao et al., Neurology, 1989, 39,

Studies Reporting Relationship between Neuropsychological Testing and MRI T2 Lesion Load 1. S. J. Huber, et al, Archives of Neurology 44, 732 (1987). 1. S. J. Huber, et al, Archives of Neurology 44, 732 (1987). 2. R. Medaer, et al, J. Neurol. 235, 86 (1987). 2. R. Medaer, et al, J. Neurol. 235, 86 (1987). 3. G. M. Franklin, et al, Neurology 38, 1826 (1988). 3. G. M. Franklin, et al, Neurology 38, 1826 (1988). 4. S. M. Rao, et al, Neurology 39, 161 (1989). 4. S. M. Rao, et al, Neurology 39, 161 (1989). 5. M. M. Callanan, et al, Brain 112, 361 (1989). 5. M. M. Callanan, et al, Brain 112, 361 (1989). 6. G. P. Anzola, et al, J. Neurol. Neurosurg. Psychiatry 53, 142 (1990). 6. G. P. Anzola, et al, J. Neurol. Neurosurg. Psychiatry 53, 142 (1990). 7. C. Pozzilli, et al, J. Neurol. Neurosurg. Psychiatry 54, 110 (1991). 7. C. Pozzilli, et al, J. Neurol. Neurosurg. Psychiatry 54, 110 (1991). 8. M. A. Ron, M. M. Callanan, E. K. Warrington, Psychol. Med. 21, 59 (1991). 8. M. A. Ron, M. M. Callanan, E. K. Warrington, Psychol. Med. 21, 59 (1991). 9. C. M. Clark, et al, Can. J. Neurol. Sci. 19, 352 (1992). 9. C. M. Clark, et al, Can. J. Neurol. Sci. 19, 352 (1992). 10. L. Pugnetti, et al, J. Neurol. Sci. 115, Suppl:S59 (1993). 11. C. Pozzilli, et al, J. Neurol. Sci. 115, Suppl:S55 (1993). 12. M. S. Damian, et al, Acta Neurol. Scand. 90, 430 (1994). 13. F. Patti, et al, Functional Neurology 10, 83 (1995).

n Significantly increased likelihood of cognitive dysfunction in patients with: u Greater overall T2 lesion area 1 u Greater T1 and T2 lesion load 2,3 u Greater number of juxtacortical lesions 4 Relationship Between Cognitive Dysfunction and Lesion Load 1 Rao SM, Leo GJ, Haughton VM, St Aubin-Faubert P, Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 1989; 39: Comi G, Rovaris M, Falautano M, Santuccio G, Martinelli V, Rocca MA, Possa F, Leocani L, Paulesu E, Filippi M. A multiparametric MRI study of frontal lobe dementia in multiple sclerosis. Journal of the Neurological Sciences 1999; 171: Rovaris M, Filippi M, Falautano M, Minicucci L, Rocca MA, Martinelli V, Comi G. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology 1998; 50: Lazeron RH, Langdon DW, Filippi M, van Waesberghe JH, Stevenson VL, Boringa JB, Origgi D, Thompson AJ, Falautano M, Polman CH, Barkhof F. Neuropsychological impairment in multiple sclerosis patients: The role of juxtacortical lesion on FLAIR. Multiple Sclerosis 2000; 6: Rao SM, Leo GJ, Haughton VM, St Aubin-Faubert P, Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 1989; 39: Comi G, Rovaris M, Falautano M, Santuccio G, Martinelli V, Rocca MA, Possa F, Leocani L, Paulesu E, Filippi M. A multiparametric MRI study of frontal lobe dementia in multiple sclerosis. Journal of the Neurological Sciences 1999; 171: Rovaris M, Filippi M, Falautano M, Minicucci L, Rocca MA, Martinelli V, Comi G. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology 1998; 50: Lazeron RH, Langdon DW, Filippi M, van Waesberghe JH, Stevenson VL, Boringa JB, Origgi D, Thompson AJ, Falautano M, Polman CH, Barkhof F. Neuropsychological impairment in multiple sclerosis patients: The role of juxtacortical lesion on FLAIR. Multiple Sclerosis 2000; 6:

Normal Appearing White Matter (NAWM) Rovaris and Filippi (2000): Rovaris and Filippi (2000): In addition to burden of lesions and severity of pathology within particular lesions, MS- associated cognitive decline associated with pathological damage in the NAWM.

Normal Appearing White Matter (NAWM) and Grey Matter n Cutting edge research using techniques such as magnetization transfer ratio and diffusion tensor imaging has enabled researchers to examine brain regions that look normal on traditional MRI scans. n There is mounting evidence that damage to neurons in NAWM and gray matter is highly correlated with cognitive deterioration in MS 1,2 1 Zivadinov R, De Masi R, Nasuelli D, Bragadin LM, Ukmar M, Pozzi-Mucelli RS, Grop A., Cazzoto G, Zorzon M. MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis. Neuroradiology 2001; 43; Rovaris M, Iannucci G, Falautano M, Possa F, Martinelli V, Comi G, Filippi M. Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging. Journal of the Neurological Sciences 2002: Zivadinov R, De Masi R, Nasuelli D, Bragadin LM, Ukmar M, Pozzi-Mucelli RS, Grop A., Cazzoto G, Zorzon M. MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis. Neuroradiology 2001; 43; Rovaris M, Iannucci G, Falautano M, Possa F, Martinelli V, Comi G, Filippi M. Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging. Journal of the Neurological Sciences 2002:

n Relationship between MR lesion burden and neuropsychological test scores n Location of lesions and neurobehavioral syndromes n Natural history studies: Correlations between changes in MR lesion burden and neuropsychological test scores MRI Correlates Of Neuropsychological Testing

WAIS-R Verbal Intelligence WCST Perseverative Responses MS Patient Subgroups <20 sq cm >20 sq cm <20 sq cm >20 sq cm Relationship between Frontal Lobe White Matter Lesions and Wisconsin Card Sorting Test* * Arnett, Rao et al., Neurology, 1994, 44,

Swirsky-Sacchetti et al. Neurology. 1992;42:1291; Sperling et al. Arch Neurol. 2001;58:115; Rovaris et al. Neurology. 1998;50:1601; Rovaris and Filippi. J Neurovirol. 2000;6(suppl 2):S172. Study Lesion locationPredicted cognitive deficit Swirsky-Frontal lobeAbstract problem solving Sacchetti Memory et al, 1992 Word fluency Left parieto-Verbal learning occipital lobe Complex visual-integrative skills SperlingFrontal and Attention et al, 2001parietal areasVerbal memory Rovaris Frontal lobe Frontal lobe functions et al, 1998lesion Correlation of Lesion Location With Cognitive Dysfunction in MS

n Relationship between MR lesion burden and neuropsychological test scores n Location of lesions and neurobehavioral syndromes n Natural history studies: Correlations between changes in MR lesion burden and neuropsychological test scores MRI Correlates Of Neuropsychological Testing

With permission from S.M. Rao. n Cognitive dysfunction correlates with T2 lesion load but not with disability (EDSS) Correlation Between MRI Lesion Load and NP Testing 3 Year Follow-up Study P=NS NP unchanged (n=62) NP worsened (n=15) EDSS EDSS score P<0.001 Total T2 Lesion Area NP unchanged (n=62) NP worsened (n=15) Lesion area (cm 2 )

MRI Correlation Between Enhancing Lesions and Brain Atrophy n The course of cerebral atrophy in MS appears to be influenced by the presence of enhancing lesions n In patients with relapsing MS and only mild-to-moderate disability, significant cerebral atrophy develops over 1 to 2 years Simon et al. Neurology. 1999;53:139.

Relationship between Atrophy and Cognition n Cognitive dysfunction has been shown to be more highly correlated with brain atrophy than T2 and T1 disease burden 1,2 n Studies looking at brain parenchymal fraction indicate that global atrophy is strongly correlated with developing cognitive dysfunction 1,2 Zivadinov et al. Neuroradiology. 2001;43:272. Zivadinov et al. J Neurol Neurosurg Psychiatry. 2001;70:773. Benedict et al. J Neuropsychiatry Clin Neurosci. 2002;14:44. Benedict et al. Arch Neurol. 2004;61:226.

Relationship between Atrophy and NP Dysfunction Simon. J Neuroimmunol. 1999;98:7. Benedict et al. J Neuropsychiatry Clin Neurosci. 2002;14:44. Benedict et al. Arch Neurol. 2004;61:226. “Nearly all correlation studies have shown associations between atrophy and disturbances in neuropsychological and clinical function.” 1 “…we conclude that cortical atrophy…is associated with cognitive dysfunction in MS.” 2,3

Atrophy as a Predictor of Cognitive Dysfunction n Brain atrophy has been found to be an independent predictor of cognitive dysfunction 1,2 n Recent research suggests that, in fact, central atrophy, as measured by third ventricle width, was more strongly predictive of cognitive dysfunction than either global atrophy or lesion load. 3 n Quantitative analysis of MRIs of patients with MS suggests that atrophy of the superior frontal lobes is associated with cognitive morbidity 3,4 Zivadinov et al. Neuroradiology. 2001;43:272. Zivadinov et al. J Neurol Neurosurg Psychiatry. 2001;70:773. Benedict et al. Arch Neurol. 2004;61:226. Benedict et al. J Neuropsychiatry Clin Neurosci. 2002;14:44.

VERBAL SPATIAL TRIALS Normal Ventricular Size (N=19) Mild Ventricular Dilatation (N=19) Mod./Severe Ventricular Dilatation (N=9) Mean words recalled Mean items recalled Atrophy And Memory Performance* *Rao et al., Archives of Neurology, 1985, 42,

Summary: Correlation of Cognitive Dysfunction with Other Assessments of MS n Strongly correlated with prior inflammatory disease activity n Strongly correlated with MRI measures u Atrophy u T2 lesion load n Weakly correlated with physical disability (EDSS) Rao. Curr Opin Neurol. 1995;8:216; Simon et al. J Neuroimmunol. 1999;98:7; Benedict et al. J Neuropsychiatry Clin Neurosci. 2002;14:44. Benedict et al. Arch Neurol. 2004;61:226.

Effect of Therapy on Cognitive Dysfunction “When considering the effects that disease modifying medications have on MRI disease activity, there is considerable hope that altering the cerebral demyelinating process will be associated with a slower decline in cognitive functions over time and result in improved activities of daily living for patients with multiple sclerosis.” Bobholz and Rao. Curr Opin Neurol. 2003;16:283.

Future Directions n With increased precision in neuroradiologic and neuropathologic techniques, researchers have been able to more accurately characterize the underlying mechanisms of cognitive deterioration in MS n Correlations between cognitive decline and brain involvement, however, remain moderate at best n This points to the complex and multifactorial etiology of MS- related cognitive dysfunction, and it indicates the need for continued neurocognitive research using the increased precision and sensitivity of newly developed radiologic and pathologic techniques 1 1 Camp SJ, Stevenson VL, Thompson AJ, Miller DH, Borras C, Auriacombe S, Brochet B, Falautano M, Filippi M, Herisse-Dulo L, Montalban X, Parrcira E, Polman CH, De Sa J, Langdon DW. Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates. Brain 1999; 122: Camp SJ, Stevenson VL, Thompson AJ, Miller DH, Borras C, Auriacombe S, Brochet B, Falautano M, Filippi M, Herisse-Dulo L, Montalban X, Parrcira E, Polman CH, De Sa J, Langdon DW. Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates. Brain 1999; 122: